Manhattan Research, which studies how consumers and physicians gather healthcare information and the impact of technology, recently released its US study of consumers - Cybercitizen Health v8.0.(Dec 14, 2008)
We recently had a chance to talk with Paul Hobbs, Director of Sales, Pfizer Australia about the sales challenges the industry faces and how it can turn those challenges into opportunities.(Dec 16, 2008)
Japan is a major presence in most larger pharmaceutical companies' contributions to their bottom lines. But as the world changes, and the healthcare environment becomes more difficult across the globe, Japan is changing, too.(Dec 16, 2008)
A dashboard can be anything a company wants it to be. It can be tailored to meet specific goals, objectives, and company structure and culture.(Jan 2, 2009)
While not solely focused on the pharma industry, recent analysis on marketing from Jupiter Research and the Verse Group, a brand consultancy, offers some keen insight drug companies could do well to note.(Jan 2, 2009)
Valeant Pharmaceuticals International today announced over the Christmas Break that the company completed its acquisition of Dow Pharmaceutical Sciences, Inc, a privately held dermatology company that(Jan 5, 2009)
Rapidly changing global market forces are challenging even the most successful companies to adapt their business models and re-think their go-to-market strategies.(Jan 5, 2009)
The Business and Competitive Intelligence functions in Pharma generally fly under the radar of noticeability to those looking at the industry, They generally remain in the shadow of the 'glory' sales,(Jan 5, 2009)
It takes 14.8 years before an idea for a drug becomes a prescription. Although compassionate use...
Although future advances in population-wide health may well be driven less by new drugs and devices...
Growth markets aren't the future for big pharma, but they could be for new business models and...